NusinersenMeSH Supplementary Concept

https://www.has-sante.fr/jcms/p_3529321/fr/spinraza-nusinersen-sodique-amyotrophie-spinale
2024
France
evaluation of the transparency committee
SPINRAZA
Nusinersen
Spinal Muscular Atrophy
muscular atrophy, spinal
nusinersen
spinal muscular atrophy, nos
nusinersen

---
https://pgtmsite.files.wordpress.com/2024/01/ad_nusinersen_pgtm_20221021_final_approbation-ce_ajustments-cs_20231130_5-1.pdf
2022
Canada
drug information
No Treatment for Diabetes
adult
muscular atrophy, spinal
hospitals, university
spinal muscular atrophy, nos
Analyzed
GDC Treatment Frequency Terminology
Spinal Muscular Atrophy
Therapy Object
nusinersen
Usage
During Treatment
Identifier
Child
Biomaterial Treatment
On Treatment
Description
Analysis
Treatment Epoch
child
child, nos
Offspring
nusinersen
Treatment Study
spinal muscular atrophies of childhood
Treatment
Treat
adulthood
Nusinersen
Legal Adult
quebec
adult children

---
https://pgtmsite.files.wordpress.com/2024/01/mic_pgtm_nusinersen_20220623_vf_2-2.pdf
2022
false
false
false
Canada
guidelines for drug use
quebec
nusinersen
Adult
Amyotrophy
muscular atrophy, spinal
adulthood
Child
Child
adult
child, nos
hospitals, university
spinal muscular atrophy, nos
Child
adult children
child
Child
Adult
nusinersen
spinal muscular atrophies of childhood

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/recommandations-sur-les-informations-requises-au-suivi-de-lusage-du-nusinersen-en-contexte-de-vie-reelle.html
2020
false
false
false
Canada
guideline
life
nusinersen
guideline adherence
oligonucleotides

---
https://pgtmsite.files.wordpress.com/2024/01/protocole-ad-nusinersen_2020_v-20210210_amendements-acceptes.pdf
2020
Canada
drug information
AD Regimen
nusinersen
Nusinersen
nusinersen

---
https://www.has-sante.fr/jcms/p_3199401/fr/spinraza
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
child
infant
insurance, health, reimbursement
injections, spinal
nusinersen
nusinersen
muscular atrophy, spinal
5q spinal muscular atrophy
oligonucleotides

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=44554
2019
false
false
false
France
insurance, health, reimbursement
nusinersen
muscular atrophy, spinal
orphan drug production
muscular atrophy, spinal
legislation
oligonucleotides

---
https://www.has-sante.fr/portail/jcms/c_2826600/fr/spinraza
https://www.has-sante.fr/portail/jcms/c_2826600/fr/spinraza-nusinersen-oligonucleotide-antisens
2018
false
false
false
France
French
treatment outcome
orphan drug production
oligonucleotides
spinal muscular atrophies of childhood
injections, spinal
survival of motor neuron 1 protein
survival of motor neuron 2 protein
genetic diseases, inborn
spinal muscular atrophies of childhood
child
infant
chromosomes, human, pair 5
nusinersen
evaluation of the transparency committee
nusinersen
guidelines for drug use

---
https://ansm.sante.fr/informations-de-securite/spinraza-nusinersen-v-information-sur-le-risque-dhydrocephalie-communicante-non-reliee-a-une-meningite-ou-a-une-hemorragie
2018
false
false
false
France
French
pharmacovigilance note
injections, spinal
nusinersen
nusinersen
communicating hydrocephalus
adult
child
signs and symptoms
communicating hydrocephalus
risk
continuity of patient care
muscular atrophy, spinal
drug monitoring
information dissemination
product surveillance, postmarketing
hydrocephalus
hydrocephalus
oligonucleotides

---
https://www.ema.europa.eu/medicines/human/EPAR/Spinraza
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
orphan drug production
oligonucleotides
oligonucleotides
product surveillance, postmarketing
spinal muscular atrophies of childhood
injections, spinal
survival of motor neuron 1 protein
survival of motor neuron 2 protein
genetic diseases, inborn
spinal muscular atrophies of childhood
child
infant
drug evaluation, preclinical
chromosomes, human, pair 5
nusinersen
nusinersen
nusinersen

---